Dan Vogl, MD MSCE, is Medical Director of the Abramson Cancer Center Clinical Research Unit at the University of Pennsylvania Perelman School of Medicine, overseeing the work of over 100 research nurses, research coordinators, regulatory coordinators, and biospecimen coordinators, who together manage over 300 active cancer clinical trials. His clinical research focuses on early phase trials of novel agents for the treatment of relapsed and refractory multiple myeloma. Dr. Vogl is a medical oncologist and hematologist who specializes in caring for patients with plasma cell malignancies, including multiple myeloma and AL amyloidosis.
Dr. Vogl is a graduate of Weill Medical College of Cornell University and has a Masters of Science in Clinical Epidemiology from the University of Pennsylvania. He completed training in Internal Medicine at Columbia-Presbyterian Hospital in New York and in Hematology and Oncology at the Hospital of the University of Pennsylvania.